Nancy Walsh, MedPage Today

Nancy Walsh

MedPage Today

Contact Nancy

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

  • Unknown
  • MedPage Today
  • Everyday Health

Past articles by Nancy:

CV Risk in PsA: Do Drugs Matter?

Study weighs in on heart safety of TNF inhibitors versus other biologics → Read More

Avacopan for ANCA Vasculitis: A New Treatment Paradigm?

Remission rates not inferior to prednisone -- the 'unthinkable' achieved → Read More

Military Burn Pits Linked With RA Seropositivity

Highest risks for anti-CCP antibodies seen for smokers and those with the HLA-DRB1 shared epitope genes → Read More

ICI-Linked Arthritis: Risks for Persistence

Less improvement in joint symptoms with longer duration of use and combo regimens → Read More

Ulcerative Colitis: Biologic Horizons Widen

Large trials show efficacy for ustekinumab and vedolizumab → Read More

Cosentyx Safety Confirmed Through 5 Years

Safety profile favorable in psoriasis, psoriatic arthritis, and ankylosing spondylitis → Read More

For Dermatomyositis, Mortality Marker ID'd

IgG2 isotype of anti-TIF1 predicted both cancer and mortality → Read More

No Rise in Cancer Risk for RA Patients on Actemra

Similar to malignancy risk with TNF inhibitors and abatacept → Read More

Hit Harder Early in PsA?

Initiation of biologic therapy early in the course of psoriatic arthritis doubled the remission rate at week 22 in a randomized trial. In patients who had previously received neither methotrexate nor a biologic agent, the remission rate among those who were given monthly subcutaneous golimumab (Simponi) plus methotrexate was 81% compared with 42% for those given methotrexate alone (P=0.004),… → Read More

Abatacept Retention Higher Without Prior Biologics

Earlier use in rheumatoid arthritis may improve efficacy → Read More

Stop Smoking and Stop RA?

Risk for rheumatoid arthritis declined with many years' cessation, but some risk remained → Read More

Cancer Treatment and Arthritis: A Growing Complaint

Will checkpoint inhibitor-related arthritis outstrip RA in frequency? → Read More

Could RA Be Prevented?

Targeting B cells during prodromal phase of rheumatoid arthritis shows promise → Read More

Bone Erosions Common in Gout

The strongest risk factor was the presence of tophi → Read More

Year in Review: Crohn's Disease

Newer treatments make inroads, but risks and obstacles remain → Read More

Clinical Challenges: Are You Up to Date on RA?

Three questions on fine-tuning treatment for rheumatoid arthritis → Read More

ACR: Success with Stem Cells in Severe Scleroderma

Patients remained off DMARDs for more than a decade → Read More

Abuse in Childhood and Arthritis Linked

The more severe and frequent the abuse, the greater the risk of arthritis in adulthood → Read More

Vasculitis: A Link with IBD?

High rates of Crohn's disease and ulcerative colitis seen in patients with giant cell arteritis → Read More

High Urate Does Predict Gout Risk

* Asymptomatic men and women were at increased risk for clinically diagnosed gout during almost 30 years of follow-up when their baseline serum urate level was elevated, according to a Swedish disease risk factor database. * Realize that asymptomatic hyperuricemia is common, with an estimated prevalence of 10% to 20% in Western populations, but only 10% to 20% of individuals with hyperuricemia… → Read More